Changeflow GovPing Pharma & Drug Safety Therapeutic Agent Delivery Methods via Ultrasou...
Routine Notice Added Final

Therapeutic Agent Delivery Methods via Ultrasound Patent Application

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published patent application EP2026030486A1 concerning methods and compositions for delivering therapeutic agents via ultrasound. The publication date is March 18, 2026, and it covers various IPC classifications related to biotechnology and drug delivery.

What changed

This document is a publication of a European patent application (EP2026030486A1) filed with the European Patent Office (EPO) concerning "Methods and Compositions for Delivery of Therapeutic Agents via Ultrasound." The publication date is March 18, 2026. The application details various International Patent Classification (IPC) codes related to biotechnology, drug formulations, and ultrasound-based delivery methods.

As this is a patent application publication, it does not impose direct compliance obligations on regulated entities. However, it signals potential future innovation and intellectual property in the field of therapeutic agent delivery. Companies involved in drug development, medical device manufacturing, or biotechnology may wish to monitor the progress of this patent application and similar filings for competitive intelligence and to understand emerging technologies.

Source document (simplified)

← EPO Patent Bulletin

METHODS AND COMPOSITIONS FOR DELIVERY OF THERAPEUTIC AGENTS VIA ULTRASOUND

Publication EP2026030486A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12N 15/85 20060101AFI20260207BHEP A61K 9/48 20060101ALI20260207BHEP A61K 31/7088 20060101ALI20260207BHEP A61K 38/36 20060101ALI20260207BHEP A61K 38/37 20060101ALI20260207BHEP A61K 41/00 20200101ALI20260207BHEP A61K 48/00 20060101ALI20260207BHEP A61P 1/16 20060101ALI20260207BHEP A61P 7/04 20060101ALI20260207BHEP C12N 15/87 20060101ALI20260207BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030486A1

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing 3254.1 Biotechnology
Activity scope
Drug Delivery
Geographic scope
European Union EU

Taxonomy

Primary area
Healthcare
Operational domain
Research & Development
Topics
Medical Devices Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.